Abiopharma

CYPHER METAVERSE INC. (META)

Symbol	META
Name	CYPHER METAVERSE INC.
Sector	TECHNOLOGY
Region	North America
Industry	-
Address	V6C 2G8 Canada BC 1780-355 Burrard Street
Telephone	+1 (778) 373-8578
Fax	—
Email	—
Website	https://www.cypher-meta.com/
Incorporation	CA
Incorporated On	2013
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	Antares Professional Corporation;
Audit Status	AUDITED
Reporting Status	International Reporting: Canadian Securities Exchange
CIK	0001721400
Description	Cypher Metaverse Inc. (Cypher, CODE, or the Company) seeks early-stage investments in emerging technology sectors, including the blockchain ecosystem, fintech and the metaverse. The Company identifies such opportunities and applies its relationships and capital to advance its interests. Additional info from NASDAQ: Meta is the worlds largest online social network, with over 3.6 billion monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. On the video side, the firm is in the process of building a library of premium content and monetizing it via ads or subscription revenue. Meta refers to this as Facebook Watch. The firms ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firms total revenue, with 50% coming from the U.S. and Canada and 25% from Europe. With gross margins above 80%, Meta operates at a 30%-plus margin. Additional info from OTC: Cypher Metaverse Inc. (Cypher, CODE, or the Company) seeks early-stage investments in emerging technology sectors, including the blockchain ecosystem, fintech and the metaverse. The Company identifies such opportunities and applies its relationships and capital to advance its interests.

2026-08-19 01:05

Powell Dina H. 🟡 adjusted position in 3.5K shares (2 derivative) of Meta Platforms, Inc. (META) at $589.85 ($2.1M) Transaction Date: Aug 15, 2026 | Filing ID: 012611

2026-08-19 00:55

Director White Dana 🟡 adjusted position in 0 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Aug 15, 2026 | Filing ID: 012610

2026-08-19 00:55

Director Arnold John Douglas 🟡 adjusted position in 0 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Aug 15, 2026 | Filing ID: 012609

2026-08-19 00:55

Director Elkann John 🟡 adjusted position in 8 shares (1 derivative) of Meta Platforms, Inc. (META) at $589.85 Transaction Date: Aug 15, 2026 | Filing ID: 012608

2026-08-19 00:52

LI SUSAN J 🟡 adjusted position in 9.0K shares (6 derivative) of Meta Platforms, Inc. (META) at $689.85 ($5.6M) Transaction Date: Aug 15, 2026 | Filing ID: 012607

2026-08-19 00:52

Anderson Aaron 🟡 adjusted position in 1.2K shares (4 derivative) of Meta Platforms, Inc. (META) at $589.85 Transaction Date: Aug 15, 2026 | Filing ID: 012606

2026-08-19 00:52

Cox Christopher K 🟡 adjusted position in 8.1K shares (4 derivative) of Meta Platforms, Inc. (META) at $589.85 ($4.8M) Transaction Date: Aug 15, 2026 | Filing ID: 012605

2026-08-19 00:50

Director Collison Patrick 🟡 adjusted position in 0 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Aug 15, 2026 | Filing ID: 012604

2026-08-19 00:49

Bosworth Andrew 🟡 adjusted position in 8.1K shares (4 derivative) of Meta Platforms, Inc. (META) at $589.85 ($4.8M) Transaction Date: Aug 15, 2026 | Filing ID: 012603

2026-08-19 00:47

Mahoney Curtis J. 🟡 adjusted position in 2.4K shares (1 derivative) of Meta Platforms, Inc. (META) at $589.85 ($1.4M) Transaction Date: Aug 15, 2026 | Filing ID: 012602